Barclays
AXGN icon

Barclays’s Axogen AXGN Stock Holding History

Barclays’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-200,000
Closed -$3.96M – 6700
2019
Q2 		$3.96M Sell
200,000
-100,000
-33% -$2.14M ﹤0.01% 2090
2019
Q1 		$6.32M Buy
+300,000
New +$5.48M ﹤0.01% 1499

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Barclays's AXGN Position: Q2 2026 in Review

Barclays increased its Axogen (AXGN) stake by 538% in Q2 2026, buying an estimated $1.99M and bringing the position to 58,414 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Barclays first reported a position in AXGN in Q1 2014 and has held it in 42 quarters since. The position peaked at $4.55M in Q1 2019. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Barclays held 58,414 shares of Axogen worth $2.7M as of Q2 2026.
  • Barclays bought 49,260 Axogen shares in Q2 2026, an estimated $1.99M.
  • Axogen made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2192 holding.
  • Barclays first reported a position in Axogen in Q1 2014 and has held it in 42 quarters since.
  • Barclays's Axogen position peaked at $4.55M in Q1 2019.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.